🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK2798745 is a potent and selective transient receptor potential vanilloid...
Status
Terminated
Location
GSK Investigational Site
Start Date
2018-04-05
Trial ID
NCT03372603
Treatments Being Tested
The primary objective of the Single Rising Dose (SRD) part (trial part 1) i...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2017-01-12
Trial ID
NCT03004404
This is a randomized, placebo-controlled, 2-period crossover, escalating re...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-02-09
Trial ID
NCT02991859
Fibromyalgia is a chronic debilitating musculoskeletal pain syndrome. Prega...
Status
Completed
Location
Jiao Juan
Start Date
2019-03-22
Trial ID
NCT03797560
Treatments Being Tested
This study seeks to evaluate the effect of intepirdine (RVT-101) on gait an...
Status
Completed
Location
US101
Start Date
2016-10
Trial ID
NCT02910102
Treatments Being Tested
The study's primary goal is to assess the effectiveness of behavioural acti...
Status
Completed
Location
St. Joseph's Healthcare Hamilton
Start Date
2014-03
Trial ID
NCT02045771
Treatments Being Tested
This project aims to provide the proof of concept for transcranial direct-c...
Status
Completed
Location
Centre Hospitalier Le Vinatier - Service de Psychiatrie Adulte
Start Date
2016-05-30
Trial ID
NCT02744989
Treatments Being Tested
The aim of this early phase two-part study was to compare the bioavailabili...
Status
Completed
Location
Quotient Sciences Ltd
Start Date
2021-11-26
Trial ID
NCT06028321
Treatments Being Tested
This study is a double-blind, randomized, placebo-controlled, 2-period, cro...
Status
Completed
Location
Site 002
Start Date
2015-12
Trial ID
NCT02633007
Treatments Being Tested
The primary purpose is to evaluate the safety and tolerability of ASP6981 i...
Status
Completed
Location
Cctmg/Parexel
Start Date
2018-01-22
Trial ID
NCT03356639